Jiangsu Hengrui Pharmaceuticals (600276.SH) plans to spend 1 to 2 billion yuan to implement a repurchase, with a repurchase price not exceeding 90.85 yuan per share.

Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that the company plans to repurchase A-shares for the A-share employee stock ownership plan; intends to use total funds of not less than 1 billion yuan and not more than 2 billion yuan; the repurchase price shall not exceed 90.85 yuan per share; the repurchase period shall not exceed 12 months from the date of approval of the repurchase plan by the board of directors.